NEJM· Paul M Ridker A. Michael Lincoff Nikolaus Marx Ann Marie Navar Naveed Sattar Katherine R. Tuttle Matthew Budoff Morten Böttcher Matthew A. Cavender Robin P. Choudhury Jan H. Cornel Grzegorz Gajos Issei Komuro K.M.K. Reddy Parvathareddy Roberto Pontremoli José Francisco Kerr Saraiva Iana I. Simova Lance A. Sloan Alejandro López-Suárez Yi-Da Tang Lale Tokgözoğlu Nqoba Tsabedze Konstantinos Tsioufis Subodh Verma Mathias Vrolix Andreas Andersen Florian M.M. Baeres Kathrine Ekström Mads D.M. Engelmann Sofia Gerward G. Kees Hovingh Anders Hvelplund and Vlado Perkovicthe ZEUS Investigators*·· 11 天前精选AI 评分62
IL-6抑制剂ziltivekimab用于动脉粥样硬化性疾病的ZEUS研究结果在NEJM发表
Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease
AI 导读
NEJM以在线预出版形式发表了ZEUS研究结果,该研究评估IL-6抑制剂ziltivekimab在动脉粥样硬化性疾病中的作用,作者包括Paul M Ridker等ZEUS研究者。当前材料仅有标题与期刊信息,未提供具体疗效或安全性数据。
来源:NEJM · nejm.org